Ligand validation:5FWY

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5FWY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FWY_NAG_D_1382	71%	60%	0.089	0.907	0.57	0.94	-	-	0	0	100%	0.9333
5FWY_NAG_A_1378	64%	49%	0.133	0.932	0.53	1.43	-	1	0	0	100%	0.9333
5FWY_NAG_C_1378	61%	54%	0.143	0.931	0.68	1.1	-	2	0	0	100%	0.9333
5FWY_NAG_B_1384	59%	54%	0.131	0.914	0.59	1.17	-	1	0	0	100%	0.9333
5FWY_NAG_C_1379	35%	45%	0.169	0.858	0.48	1.62	-	3	0	0	100%	0.9333
5FWY_NAG_B_1383	34%	59%	0.177	0.86	0.5	1.05	-	-	0	0	100%	0.9333
5FWY_NAG_D_1381	33%	49%	0.163	0.843	0.54	1.39	-	3	0	0	100%	0.9333
5FWY_NAG_A_1379	31%	43%	0.187	0.856	0.54	1.65	-	4	0	0	100%	0.9333
5FWY_NAG_B_1385	21%	29%	0.232	0.844	0.5	2.3	-	5	0	0	100%	0.9333
5FWY_NAG_D_1383	18%	56%	0.226	0.812	0.49	1.17	-	1	0	0	100%	0.9333
6FPJ_NAG_B_401	85%	58%	0.092	0.958	0.57	1.04	-	2	0	0	100%	0.9333
3O21_NAG_A_391	67%	25%	0.09	0.898	1.71	1.33	3	3	0	0	100%	0.9333
6FLR_NAG_A_403	24%	65%	0.203	0.842	0.38	0.96	-	1	0	0	93%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.